COR news

Cencora, Inc. · end-of-day data as of Oct 16, 2026

Cencora, Inc.

COR · $65.06B

$340.92+10.2%last 60 sessions · close Oct 16, 2026

$251.67$372.5252 weeks

Buy · 15 analystsPT $364.08 +6.8%

P/E vs own-19.0%
P/E vs sector-10.0%
Target upside+6.8%
Off 52w high-8.5%
Insiders-$4.69M
FCF yield+6.2%
Earnings in19d
Trendsideways
Sector▲ +16.0%
RSI70
MA20×50↑ in ~6d
Volume1.6x
Support-1.7%
Resistance+2.3%

Last session

News0.00

Headlines

Cencora (NYSE:COR) and Option Care Health (NASDAQ:OPCH) Financial Contrast
Defense World · Oct 17, 2026
AI Disruption May Benefit Cencora More Than Hims & Hers
Seeking Alpha · Oct 14, 2026
23,420 Cencora, Inc. $COR Shares Bought by NorthCrest Asset Manangement LLC
Defense World · Oct 13, 2026
Hims & Hers Health (NYSE:HIMS) vs. Cencora (NYSE:COR) Head to Head Review
Defense World · Oct 12, 2026
Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs Grow
Seeking Alpha · Oct 6, 2026
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release
Business Wire · Oct 2, 2026
Cencora Elects Robert E. Sanchez to Its Board of Directors
Business Wire · Sep 25, 2026
Here's Why Cencora (COR) is a Strong Growth Stock
Zacks Investment Research · Sep 23, 2026
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027
MarketBeat · Sep 21, 2026
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference
Defense World · Sep 21, 2026
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference
MarketBeat · Sep 21, 2026
Here's Why Cencora (COR) is a Strong Value Stock
Zacks Investment Research · Sep 18, 2026
Corient Private Wealth LP Purchases 19,068 Shares of Cencora, Inc. $COR
Defense World · Sep 17, 2026
Cencora, Inc. (COR) Presents at 2026 Global Healthcare Conference Transcript
Seeking Alpha · Sep 15, 2026
Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha · Sep 15, 2026
3,733,921 Shares in Cencora, Inc. $COR Purchased by Bank of America Corp DE
Defense World · Sep 15, 2026
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Fool - Investing News · Sep 14, 2026
Here's Why Cencora (COR) is a Strong Momentum Stock
Zacks Investment Research · Sep 10, 2026
Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha · Sep 8, 2026
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Zacks Investment Research · Sep 7, 2026
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now
Zacks Investment Research · Sep 4, 2026
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue?
Zacks Investment Research · Sep 4, 2026
Cencora Launches Cell and Gene Therapy Enablement for Health Systems
Zacks Investment Research · Sep 4, 2026
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen
Zacks Investment Research · Sep 3, 2026
Cencora's Accelerate Pharmacy Solutions Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs
Business Wire · Sep 2, 2026
Connor Clark & Lunn Investment Management Ltd. Invests $841,000 in Cencora, Inc. $COR
Defense World · Aug 31, 2026
Invesco Discovery Mid Cap Growth Fund Q2 2026 Portfolio Performance
Seeking Alpha · Aug 23, 2026
Advisors Capital Management LLC Takes $748,000 Position in Cencora, Inc. $COR
Defense World · Aug 22, 2026
"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.
Fool - Investing News · Aug 19, 2026
Why Cencora (COR) is a Top Value Stock for the Long-Term
Zacks Investment Research · Aug 12, 2026

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.